Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics in liver diseases.

Antonello Pietrangelo1, Ronald Oude Elferink, Jesus Prieto

  • 1Center for Hemochromatosis, University Hospital of Modena, Via del Pozza 71, 41100 Modena, Italy. pietrangelo.antonello@unimore.it

Journal of Hepatology
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registry.

Journal of hepatology·2026
Same author

Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets.

Orphanet journal of rare diseases·2025
Same author

Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major.

Scientific reports·2025
Same author

Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients.

International journal of pharmaceutics·2025
Same author

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.

Hepatology communications·2025
Same author

Diagnosis and Management of Non-HFE Hemochromatosis, Ferroportin Disease, and Rare Hereditary Iron-Loading Disorders.

Advances in experimental medicine and biology·2025
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
Same journal

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
See all related articles

Recent advances in liver genetics and molecular biology were discussed at a joint EASL/AASLD conference. Key breakthroughs and their implications for hepatology were summarized for clinicians and researchers.

Area of Science:

  • Hepatology
  • Medical Genetics
  • Molecular Biology

Background:

  • The liver field has seen significant recent discoveries, especially in molecular biology and genetics.
  • Hepatologists require updated knowledge on genetic breakthroughs impacting liver disease.

Framework:

  • A joint European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD) Monothematic Conference.
  • Focused on integrating the latest genetic advancements into hepatology practice and research.

Implementation:

  • Conference held June 23rd-24th, 2006, in Modena, Italy.
  • Brought together experts to discuss breakthroughs in genetics relevant to liver diseases.

Implications:

Related Experiment Videos

  • Summarizes key conclusions and their impact on clinical and experimental hepatology.
  • Highlights the importance of genetics in understanding and treating liver conditions.